戻る
「早戻しボタン」を押すと検索画面に戻ります。

今後説明を表示しない

[OK]

コーパス検索結果 (1語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1  implicated in the pathogenesis of cutaneous polyarteritis nodosa (cPAN) and early-onset vasculopathy
2 noch-Schonlein purpura (HSP) and macroscopic polyarteritis nodosa (PAN) as early manifestations of Ig
3                                              Polyarteritis nodosa (PAN) has been used as a generic te
4                                              Polyarteritis nodosa (PAN) is a rare disease of childhoo
5                                              Polyarteritis nodosa (PAN) is regarded rightly as the gr
6 ment as a relatively common manifestation of polyarteritis nodosa (PAN), using the modern classificat
7 henotype, as well as two young siblings with polyarteritis nodosa and one patient with small-vessel v
8                        A study of idiopathic polyarteritis nodosa demonstrates greater similarity to
9                                 The study of polyarteritis nodosa has additionally been affected by p
10                                              Polyarteritis nodosa is a form of necrotizing vasculitis
11                                              Polyarteritis nodosa is a systemic necrotizing vasculiti
12 1 mutations, whereas the three patients with polyarteritis nodosa or small-vessel vasculitis were hom
13 's granulomatosis, inflammatory myopathy, or polyarteritis nodosa rather than rheumatoid arthritis, a
14 extracellular adenosine deaminase, can cause polyarteritis nodosa vasculopathy with highly varied cli
15 akayasu arteritis, giant cell arteritis, and polyarteritis nodosa) to atherosclerosis, display remark
16 aphy findings led to a clinical diagnosis of polyarteritis nodosa, and immunosuppressive therapy was
17  Wegener's granulomatosis, Cogan's syndrome, polyarteritis nodosa, and systemic lupus erythematosus.
18 age, treating Kawasaki disease, and treating polyarteritis nodosa, but most reported feeling comforta
19 ith multiple cases of systemic and cutaneous polyarteritis nodosa, consistent with autosomal recessiv
20 ication criteria for Wegener granulomatosis, polyarteritis nodosa, giant-cell arteritis, and hypersen
21  for vasculitis-related hospitalizations for polyarteritis nodosa, hypersensitivity vasculitis, Wegen
22 pathy (recurrent fevers, livedo reticularis, polyarteritis nodosa, lacunar ischemic strokes, and intr
23 ystemic vasculitides with neuropathy include polyarteritis nodosa, microscopic polyangiitis (MPA), rh
24 y in patients with Wegener's granulomatosis, polyarteritis nodosa, microscopic polyangiitis, and Chur
25 anulomatosis, polymyositis, dermatomyositis, polyarteritis nodosa, or scleroderma who had an emergent
26  of the first case of idiopathic vasculitis, polyarteritis nodosa, which even today is the basis of o
27 is of other primary vasculitides, especially polyarteritis nodosa.
28 man in her 50s with a diagnosis of cutaneous polyarteritis nodosa.
29  60% of Nppb-/- females developed mesenteric polyarteritis-nodosa (PAN)-like vasculitis in their life
30 tosis, microscopic polyangiitis (microscopic polyarteritis), the Churg-Strauss syndrome, idiopathic p
31 itis disorders (necrotizing arteritis of the polyarteritis type, hypersensitivity vasculitis, systemi

WebLSDに未収録の専門用語(用法)は "新規対訳" から投稿できます。